• Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit

  2026-07-21

  The Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit addresses the challenge of high-resolution separation of proteins and peptides in the 1–10 kDa range, where conventional Tris-glycine SDS-PAGE is inadequate. It is intended strictly for research workflows and is not suitable for diagnostic or clinical use.

• Lipo3K Transfection Reagent: Powering Advanced Gene Expressi

  2026-07-20

  Lipo3K Transfection Reagent streamlines high-efficiency nucleic acid delivery, even in challenging and sensitive cell lines, with minimal cytotoxicity. Its unique workflow flexibility and nuclear delivery enhancer unlock reliable results for gene expression and RNA interference research, making it a robust choice for cutting-edge experimental designs.

• Hydroxycinnamic Acids Disrupt COPII-STING Axis to Attenuate

  2026-07-20

  This study uncovers how hydroxycinnamic acids (HCAs) from traditional medicinal plants directly target the COPII cargo sorting machinery, competitively inhibiting STING trafficking and dampening cGAS-STING-driven inflammation. The findings offer a detailed mechanistic rationale for the metabolic and anti-inflammatory benefits of HCA-rich therapies and open new avenues for targeting autoinflammatory disorders.

• PD0325901 MEK Inhibitor: Applied Workflows for Cancer Resear

  2026-07-19

  Harness the power of PD0325901 for precise inhibition of the RAS/RAF/MEK/ERK pathway in oncology and stem cell models. This guide delivers actionable protocols, troubleshooting strategies, and direct translation of pioneering chromatin accessibility research into practical MEK inhibitor assay design.

• Vincristine Sulfate in Cancer Research: Protocols & Innovati

  2026-07-18

  Vincristine sulfate is a gold-standard microtubule disrupter with unmatched flexibility for cancer research, enabling precision in both in vitro and in vivo assays. This article details advanced workflows, troubleshooting strategies, and protocol enhancements to maximize its antitumor efficacy—helping researchers overcome common experimental hurdles.

• Chlorambucil: Strategic Leverage for Translational Oncology

  2026-07-17

  This thought-leadership article explores the mechanistic and translational significance of chlorambucil, a nitrogen mustard alkylating agent, for cancer researchers. By integrating recent advances in in vitro drug response quantification and workflow optimization, we provide actionable guidance for leveraging APExBIO's high-purity chlorambucil in cutting-edge cytotoxicity assays, with a focus on reproducibility, mechanistic insight, and translational impact.

• S-Adenosylmethionine (SAM): Methionine Metabolism and Fibros

  2026-07-17

  Discover how S-adenosylmethionine (SAM) modulates methionine metabolism to influence autophagy and liver fibrosis, with new insights for advanced methylation research. Explore the latest mechanistic findings and practical assay guidance in this in-depth cornerstone analysis.

• Toremifene in Prostate Cancer: Bridging Hormone and Calcium

  2026-07-16

  Explore how Toremifene, a selective estrogen-receptor modulator, empowers translational researchers to dissect the interplay between hormone and calcium pathways in prostate cancer. This article integrates mechanistic insights from recent metastasis studies with actionable protocol guidance, competitive benchmarking, and a forward-looking perspective on experimental opportunities.

• Tioconazole in Antifungal Drug Development: Protocols & Prec

  2026-07-16

  Tioconazole stands out as an antifungal medication for research, combining potent ergosterol inhibition with high solubility and purity. This article translates advanced studies into stepwise workflows, comparative insights, and troubleshooting strategies for robust antifungal drug development.

• CCT007093: Precision PPM1D Inhibitor for Dissecting Pyroptos

  2026-07-15

  CCT007093 is a selective PPM1D inhibitor that enables researchers to interrogate the p38 MAPK signaling pathway in both cancer and acute kidney injury models. Its well-characterized mechanism and quantifiable effects on cellular pyroptosis and cytotoxicity make it a strategic tool for uncovering pathway-specific outcomes and troubleshooting complex bench workflows.

• Aneugen Molecular Mechanisms: Insights from 27 Reference Che

  2026-07-15

  The referenced study introduces a tiered molecular assay to distinguish aneugenic mechanisms—tubulin destabilization, stabilization, and mitotic kinase inhibition—across a curated panel of 27 chemicals. By integrating biomarkers and machine learning classification, the assay advances reliable molecular target identification and enhances genomic safety profiling in chemical and drug research.

• PPM-18 for Advanced NF-κB-iNOS Inhibition in Sepsis Models

  2026-07-14

  PPM-18 (N-(1,4-dihydro-1,4-dioxo-2-naphthalenyl)-benzamide) empowers inflammation and sepsis research with precision NF-κB pathway inhibition and robust iNOS expression modulation. This guide translates cutting-edge mechanistic insights into actionable experimental protocols and troubleshooting strategies for translational immunology.

• Vincristine Sulfate (A1765): Reliable Strategies for Cell-Ba

  2026-07-14

  This article delivers scenario-driven, evidence-based guidance for leveraging Vincristine sulfate (SKU A1765) in cancer research workflows. Drawing on real laboratory challenges, it demonstrates how APExBIO's formulation offers reproducibility, protocol flexibility, and robust efficacy in cytotoxicity, proliferation, and viability assays.

• Renal Vascular K+ Channel Blockade Alters Blood Flow in Seps

  2026-07-13

  This study investigates how K+ channel blockers affect renal blood flow and vascular responsiveness to vasoactive agents in septic rats. The findings reveal that inhibition of distinct K+ channel subtypes can compromise perfusion in the kidneys during sepsis, underscoring the complexity of potassium channel regulation in septic shock and its implications for vascular biology research.

• Vaccinia Virus F1L Inhibits NLRP1 Inflammasome via Ribotoxic

  2026-07-13

  The referenced study demonstrates that the vaccinia virus F1L protein selectively inhibits the activation of the NLRP1 inflammasome by blocking ribotoxic stress and dsRNA-dependent pathways, but not DPP9-inhibition-mediated activation. This work clarifies viral evasion of innate immunity and underscores the complexity of inflammasome regulation in epithelial cells.

8538 records 7/570 page Previous Next First page 上5页 678910 下5页 Last page